Literature DB >> 31087069

New requirements for clinical trial transparency provide new opportunities for informatics research.

Betsy L Humphreys.   

Abstract

Mesh：

Year:  2019        PMID： 31087069      PMCID： PMC7647345          DOI： 10.1093/jamia/ocz047

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN： 1067-5027            Impact factor:   4.497


× No keyword cloud information.
  10 in total

1.  Clinical trial registration--looking back and moving ahead.

Authors:  Christine Laine; Richard Horton; Catherine D DeAngelis; Jeffrey M Drazen; Frank A Frizelle; Fiona Godlee; Charlotte Haug; Paul C Hébert; Sheldon Kotzin; Ana Marusic; Peush Sahni; Torben V Schroeder; Harold C Sox; Martin B Van der Weyden; Freek W A Verheugt
Journal:  N Engl J Med       Date:  2007-06-04       Impact factor: 91.245

2.  Reaping the Bounty of Publicly Available Clinical Trial Consent Forms.

Authors:  Holly Fernandez Lynch; Emily A Largent; Deborah A Zarin
Journal:  IRB       Date:  2017 Nov-Dec

3.  Advancing biomedical and health informatics knowledge through reviews of existing research.

Authors:  Suzanne Bakken
Journal:  J Am Med Inform Assoc       Date:  2019-04-01       Impact factor: 4.497

4.  The journey to transparency, reproducibility, and replicability.

Authors:  Suzanne Bakken
Journal:  J Am Med Inform Assoc       Date:  2019-03-01       Impact factor: 4.497

5.  Clinical Trials Registration and Results Information Submission. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2016-09-21

6.  Federal Policy for the Protection of Human Subjects. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2017-01-19

7.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  PLoS Med       Date:  2010-03-24       Impact factor: 11.069

8.  Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.

Authors:  Melanie Calvert; Derek Kyte; Rebecca Mercieca-Bebber; Anita Slade; An-Wen Chan; Madeleine T King; Amanda Hunn; Andrew Bottomley; Antoine Regnault; An-Wen Chan; Carolyn Ells; Daniel O'Connor; Dennis Revicki; Donald Patrick; Doug Altman; Ethan Basch; Galina Velikova; Gary Price; Heather Draper; Jane Blazeby; Jane Scott; Joanna Coast; Josephine Norquist; Julia Brown; Kirstie Haywood; Laura Lee Johnson; Lisa Campbell; Lori Frank; Maria von Hildebrand; Michael Brundage; Michael Palmer; Paul Kluetz; Richard Stephens; Robert M Golub; Sandra Mitchell; Trish Groves
Journal:  JAMA       Date:  2018-02-06       Impact factor: 56.272

9.  SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krleža-Jerić; Asbjørn Hróbjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Doré; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

10.  How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider.

Authors:  Tony Tse; Kevin M Fain; Deborah A Zarin
Journal:  BMJ       Date:  2018-05-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.